Clinical Trial Update: Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ABT-335 in combination with three different statins in subjects with mixed dyslipidemia, examining long-term safety and efficacy. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Dyslipidemia
• Mixed Dyslipidemia

Drugs mentioned

• ABT-335

Snippet

Sponsor: Abbott | Conditions: Dyslipidemia, Coronary Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-07-23